Erratum

Regarding the article “Diagnostic evaluation of risk for bleeding in cardiac surgery with extracorporeal circulation”, with DOI number: 1518-8345.2523.3092, published in Rev. Latino-Am. Enfermagem, 2018;26:e3092, page 5:

Where was written:

Table 2
Analysis of the association between the risk factor and bleeding, expressed by the Odds ratio. Rio de Janeiro, RJ, Brazil, 2013-2015

Risk factors	Cases	Controls	Odds ratio and significance
	N	n	OR*	CI† 95%	p value ‡
Preoperative period
Diagnosed systemic high blood pressure	20	170	0.64	(0.20 to 2.06)	0.4627
Platelet antiaggregation < 5 days	22	62	0.90	(0.35 to 2.29)	0.8353
Prothrombin activation time > 14 seconds	16	38	0.75	(0.28 to 1.98)	0.5650
Activated partial thromboplastin time > 40 seconds	13	38	1.24	(0.50 to 3.07)	0.6343
Hematocrit > 30%§	0	10	0.35	(0.02 to 6.24)	0.4788
Platelets < 150,000 cells/mm3||	6	18	1.72	(0.53 to 5.53)	0.3633
Body mass index < 26.35kg/m²¶	19	98	3.64	(1.31 to 10.15)	0.0134**
Intraoperative period
ECC†† > 90 minutes	46	121	3.57	(1.17 to 10.85)	0.0247**
Surgery > 300 minutes	27	72	1.15	(0.49 to 2.71)	0.7364
Esophageal temperature < 32°C‡‡	34	55	2.86	(1.16 to 7.00)	0.0215**
Additional hydric volume in ECC††	29	78	1.18	(0.50 to 2.79)	0.6993
Heparin reinforcement in ECC††	25	54	2.28	(0.96 to 5.40)	0.0607
Postoperative period
High blood pressure of difficult control	17	45	0.73	(0.23 to 2.27)	0.5951
Metabolic acidosis	18	58	3.50	(1.35 to 9.05)	0.0098**
Hematocrit < 30%§	8	14	2.39	(0.80 to 7.14)	0.1172
Platelets < 150,000 cells/mm3||	19	42	1.90	(0.80 to 4.50)	0.1409
Activated partial thromboplastin time > 40 seconds	21	39	2.55	(1.08 to 6.03)	0.0324**
Prothrombin activation time > 14 seconds	44	124	1.57	(0.34 to 7.10)	0.5573

• *Odds ratio; †95% confidence interval; ‡p value; §Percentage; ||Cubic millimeters; ¶Kilos per square meter; **Statistical significance; ††Extracorporeal circulation; ‡‡Degrees Celsius

Now Read:

Table 2
Analysis of the association between the risk factor and bleeding, expressed by the Odds ratio. Rio de Janeiro, RJ, Brazil, 2013-2015

Risk factors	Cases	Controls	Odds ratio and significance
	N	n	OR*	CI† 95%	p value ‡
Preoperative period
Diagnosed systemic high blood pressure	20	170	0.64	(0.20 to 2.06)	0.4627
Platelet antiaggregation < 5 days	13	143	0.40	(0.17 to 0.96)	0.040
Prothrombin activation time > 14 seconds	6	59	0.75	(0.28 to 1.98)	0.5650
Activated partial thromboplastin time > 40 seconds	8	55	1.24	(0.50 to 3.07)	0.6343
Hematocrit > 30%§	0	10	0.35	(0.02 to 6.24)	0.4788
Platelets < 150,000 cells/mm3||	4	20	1.72	(0.53 to 5.53)	0.3633
Body mass index < 26.35kg/m²¶	19	98	3.64	(1.31 to 10.15)	0.0134**
Intraoperative period
ECC†† > 90 minutes	20	112	3.57	(1.17 to 10.85)	0.0247**
Surgery > 300 minutes	13	97	1.15	(0.49 to 2.71)	0.7364
Esophageal temperature < 32°C‡‡	16	79	2.86	(1.16 to 7.00)	0.0215**
Additional hydric volume in ECC††	14	104	1.18	(0.50 to 2.79)	0.6993
Heparin reinforcement in ECC††	14	73	2.28	(0.96 to 5.40)	0.0607
Postoperative period
High blood pressure of difficult control	4	41	0.73	(0.23 to 2.27)	0.5951
Metabolic acidosis	8	24	3.50	(1.35 to 9.05)	0.0098**
Hematocrit < 30%§	5	19	2.39	(0.80 to 7.14)	0.1172
Platelets < 150,000 cells/mm3||	11	59	1.90	(0.80 to 4.50)	0.1409
Activated partial thromboplastin time > 40 seconds	12	54	2.55	(1.08 to 6.03)	0.0324**
Prothrombin activation time > 14 seconds	22	168	1.57	(0.34 to 7.10)	0.5573

• *Odds ratio; †95% confidence interval; ‡p value; §Percentage; ||Cubic millimeters; ¶Kilos per square meter; **Statistical significance; ††Extracorporeal circulation; ‡‡Degrees Celsius

Publication Dates

• Publication in this collection
  16 May 2019
• Date of issue
  2019